Transcriptional activation of the human prostatic acid phosphatase gene by NF-κB via a novel hexanucleotide-binding site

Nucleic Acids Research

Volumn 32, Issue 12, 2004, Pages 3566-3580

  Zelivianski, Stanislav ^a,c   Glowacki, Richard ^b   Lin, Ming Fong ^a,b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE PROSTATE ISOENZYME; ANDROGEN; CIS ACTING ELEMENT; DIFFERENTIATION ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NUCLEOTIDE; PROTEIN TYROSINE PHOSPHATASE; SYNAPTOTAGMIN; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA; I KAPPA B; INTERLEUKIN 1; OLIGONUCLEOTIDE;

ANTIGEN SPECIFICITY; ARTICLE; BINDING SITE; CANCER CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; ENHANCER REGION; FEMALE; GEL MOBILITY SHIFT ASSAY; GENE ACTIVITY; GENE DELETION; GENE EXPRESSION REGULATION; GENE SEQUENCE; GENETIC ANALYSIS; HELA CELL; HUMAN; HUMAN CELL; INHIBITION KINETICS; MALE; MOLECULAR CLONING; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; PROSTATE EPITHELIUM; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN MOTIF; TRANSCRIPTION INITIATION; UPREGULATION; UTERINE CERVIX CANCER; DNA FLANKING REGION; DNA FOOTPRINTING; GENETICS; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PROSTATE; PROSTATE TUMOR; TRANSACTIVATION; TUMOR CELL LINE;

5' FLANKING REGION; BASE SEQUENCE; BINDING SITES; CELL LINE, TUMOR; DNA FOOTPRINTING; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENHANCER ELEMENTS (GENETICS); GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; I-KAPPA B PROTEINS; INTERLEUKIN-1; MALE; MOLECULAR SEQUENCE DATA; NF-KAPPA B; OLIGONUCLEOTIDES; PROMOTER REGIONS (GENETICS); PROSTATE; PROSTATIC NEOPLASMS; PROTEIN-TYROSINE-PHOSPHATASE; TRANS-ACTIVATION (GENETICS); TUMOR NECROSIS FACTOR-ALPHA;

EID: 3042764572     PISSN: 03051048     EISSN: None     Source Type: Journal    
DOI: 10.1093/nar/gkh677     Document Type: Article

References (77)

1. Greenlee,R.T., Hill-Harmon,M.B., Murray,T. and Thun,M. (2001) Cancer statistics. CA Cancer J. Clin., 51, 15-36.
2. Small,E.J. (1999) Advances in prostate cancer. Curr. Opin. Oncol., 11, 226-235.
3. Nupponen,N. and Visakorpi,T. (1999) Molecular biology of progression of prostate cancer. Eur. Urol., 35, 351-354.
4. Sokoll,L.J. and Chan,D.W. (1997) Prostate-specific antigen. Its discovery and biochemical characteristics. Urol. Clin. North Am., 24, 253-259.
5. Israeli,R.S., Powell,C.T., Fair,W.R. and Heston,W.D. (1993) Molecular cloning of a complementary DNA encoding a prostate-specific membrane antigen. Cancer Res., 53, 227-230.
6. He,W.W., Sciavolino,P.J., Wing,J., Augustus,M., Hudson,P., Meissner,P.S., Curtis,R.T., Shell,B.K., Bostwick,D.G., Tindall,D.J., Gelmann,E.P., Abate-Shen,C. and Carter,K.C. (1997) A novel human prostate-specific, androgen-regulated homeobox gene (NKX3.1) that maps to 8p21, a region frequently deleted in prostate cancer. Genomics, 43, 69-77.
7. de Kok,J.B., Verhaegh,G.W., Roelofs,R.W., Hessels,D., Kiemeney,L.A., Aalders,T.W., Swinkels,D.W. and Schalken,J.A. (2002) DD3PCA3, a very sensitive and specific marker to detect prostate tumors. Cancer Res., 62, 2695-2698.
8. Henttu,P. and Vihko,P. (1992) Steroids inversely affect the biosynthesis and secretion of human prostatic acid phosphatase and prostate-specific antigen in the LNCaP cell line. J. Steroid. Biochem. Mol. Biol., 41, 349-360.
9. Virkkunen,P., Hedberg,P., Palvimo,J.J., Birr,E., Porvari,K., Ruokonen,M., Taavitsainen,P., Janne,O.A. and Vihko,P. (1994) Structural comparison of human and rat prostate-specific acid phosphatase genes and their promoters: identification of putative androgen response elements. Biochem. Biophys. Res. Commun., 202, 49-57.
10. Lin,M.F., DaVolio,J. and Garcia Arenas,R. (1992) Expression of human prostatic acid phosphatase activity and the growth of prostate carcinoma cells. Cancer Res., 52, 4600-4607.
11. Solin,T., Kontturi,M., Pohlmann,R. and Vihko,P. (1990) Gene expression and prostate specificity of human prostatic acid phosphatase (PAP): evaluation by RNA blot analyses. Biochim. Biophys. Acta, 1048, 72-77.
12. Zelivianski,S., Comeau,D. and Lin,M.F. (1998) Cloning and analysis of the promoter activity of the human prostatic acid phosphatase gene. Biochem. Biophys. Res. Commun., 245, 108-112.
13. Lin,M.F., Lee,M.S., Zhou,X.W., Andressen,J.C., Meng,T.C., Johansson,S.L., West,W.W., Taylor,R.J., Anderson,J.R. and Lin,F.F. (2001) Decreased expression of cellular prostatic acid phosphatase increases tumorigenicity of human prostate cancer cells. J. Urol., 166, 1943-50.
14. Chu,T.M. and Lin,M.F. (1998) PSA and acid phosphatase in the diagnosis of prostate cancer. J. of Clin. Lig. Assay, 21, 24-34.
15. Lin,M.F. and Clinton,G.M. (1988) The epidermal growth factor receptor from prostate cells is dephosphorylated by a prostate-specific phosphotyrosyl phosphatase. Mol. Cell. Biol., 8, 5477-5485.
16. Meng,T.C. and Lin,M.F. (1998) Tyrosine phosphorylation of c-ErbB-2 is regulated by the cellular form of prostatic acid phosphatase in human prostate cancer cells. J. Biol. Chem., 273, 22096-22104.
17. Lin,M.F., Meng,T.C., Rao,P.S., Chang,C., Schonthal,A.H. and Lin,F.F. (1998) Expression of human prostatic acid phosphatase correlates with androgen-stimulated cell proliferation in prostate cancer cell lines. J. Biol. Chem., 273, 5939-5947.
18. Meng,T.C., Lee,M.S. and Lin,M.F. (2000) Interaction between protein tyrosine phosphatase and protein tyrosine kinase is involved in androgen-promoted growth of human prostate cancer cells. Oncogene, 19, 2664-2677.
19. Lin,M.F. and Clinton,G.M. (1997) Human prostatic acid phosphatase and its phosphotyrosil protein phosphatase activity. Adv. Prot. Phosphatses, 4, 199-208.
20. Lin,M.F., Garcia Arenas,R., Chao,Y.C., Lai,M.M., Patel,P.C. and Xia,X.Z. (1993) Regulation of prostatic acid phosphatase expression and secretion by androgen in LNCaP human prostate carcinoma cells. Arch. Biochem. Biophys., 300, 384-390.
21. Shan,J.D., Porvari,K., Ruokonen,M., Karhu,A., Launonen,V., Hedberg,P., Oikarinen,J. and Vihko,P. (1997) Steroid-involved transcriptional regulation of human genes encoding prostatic acid phosphatase, prostate-specific antigen, and prostate-specific glandular kallikrein. Endocrinology, 138, 3764-3770.
22. Banas,B., Blaschke,D., Fittler,F. and Horz,W. (1994) Analysis of the promoter of the human prostatic acid phosphatase gene. Biochim. Biophys. Acta, 1217, 188-194.
23. Schuur,E.R., Henderson,G.A., Kmetec,L.A., Miller,J.D., Lamparski,H.G. and Henderson,D.R. (1996) Prostate-specific antigen expression is regulated by an upstream enhancer. J. Biol. Chem., 271, 7043-7051.
24. Kasper,S., Rennie,P.S., Bruchovsky,N., Sheppard,P.C., Cheng,H., Lin,L., Shiu,R.P., Snoek,R. and Matusik,R.J. (1994) Cooperative binding of androgen receptors to two DNA sequences is required for androgen induction of the probasin gene. J. Biol. Chem., 269, 31763-31769.
25. Zelivianski,S., Igawa,T., Lim,S., Taylor,R. and Lin,M.F. (2002) Identification and characterization of regulatory elements of the human prostatic acid phosphatase promoter. Oncogene, 21, 3696-3705.
26. Grilli,M. and Memo,M. (1999) Nuclear factor-kappaB/Rel proteins: a point of convergence of signalling pathways relevant in neuronal function and dysfunction. Biochem. Pharmacol., 57, 1-7.
27. Ghosh,S., May,M.J. and Kopp,E.B. (1998) NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol., 16, 225-260.
28. Ghosh,S. and Karin,M. (2002) Missing pieces in the NF-kappaB puzzle. Cell, 109 (Suppl), S81-S96.
29. Karin,M. and Ben-Neriah,Y. (2000) Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu. Rev. Immunol., 18, 621-623.
30. Miyamoto,S. and Verma,I.M. (l995)Rel/NF-kB/IκB story. Adv. Cancer Res., 66, 255-292.
31. Grundstrom,S., Anderson,P., Scheipers,P. and Sundstedt,A. (2004) Bcl-3 and NF-κB p50-p50 homodimers act as transcriptional repressors in tolerant CD4+ T cells. J. Biol. Chem., 279, 8460-8468.
32. Michel,F., Soler-Lopez,M., Petosa,C., Cramer,P., Siebenlist,U. and Muller,C.W. (2001) Crystal structure of the ankyrin repeat domain of Bcl-3: a unique member of the IκB protein family. EMBO J., 20, 6180-6190.
33. Chen,Z.J., Parent,L. and Maniatis,T. (1996) Site-specific phosphorylation of IkappaBalpha by a novel ubiquitination- dependent protein kinase activity. Cell, 84, 853-862.
34. Thanos,D. and Maniatis, T. (1995) NF-kappa B: a lesson in family values. Cell, 80, 529-532.
35. Pahl,H.L.( 1999) Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene, 18, 6853-6866.
36. Nakshatri,H., Bhat-Nakshatri,P., Martin,D.A., Goulet,R.J.,Jr and Sledge,G.W.,Jr (1997) Constitutive activation ot NF-kappaB during progression of breast cancer to hormone-independent growth. Mol. Cell Biol., 17, 3629-3639.
37. Palayoor,S.T., Youmell,M.Y., Calderwood,S.K., Coleman,C.N. and Price,B.D. (1999) Constitutive activation of IkappaB kinase alpha and NF-kappaB in prostate cancer cells is inhibited by ibuprofen. Oncogene, 18, 7389-7394.
38. Sumitomo,M., Tachibana,M., Nakashima,J., Murai,M., Miyajima,A., Kimura,F., Hayakawa,M. and Nakamura,H. (1999) An essential role for nuclear factor kappa B in preventing TNF-alpha- induced cell death in prostate cancer cells. J. Urol., 161, 674-679.
39. Palvimo,J.J., Reinikainen,P., Ikonen,T., Kallio,P.J., Moilanen,A. and Janne,O.A. (1996) Mutual transcriptional interference between RelA and androgen receptor. J. Biol. Chem., 271, 24151-24156.
40. Lin,M.F., Lee,C.L. and Clinton,G.M. (1986) Tyrosyl kinase activity is inversely related to prostatic acid phosphatase activity in two human prostate carcinoma cell lines. Mol. Cell Biol., 6, 4753-4757.
41. Vihko,P., Virkkunen,P., Henttu,P., Roiko,K., Solin,T. and Huhtala,M.L. (1988) Molecular cloning and sequence analysis of cDNA encoding human prostatic acid phosphatase. FEBS Lett., 236, 275-281.
42. Sharief,F.S. and Li,S.S. (1994) Nucleotide sequence of human prostatic acid phosphatase ACPP gene, including seven Alu repeats. Biochem. Mol. Biol. Int., 33, 561-565.
43. Quandt,K., Frech,K., Karas,H., Wingender,E. and Werner,T. (1995) MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res., 23, 4878-4884.
44. Sambrook,J., Fritsch,E.F. and Maniatis,T. (1989) Molecular Cloning: A Laboratory Manual, 2nd edn. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
45. Bradford,M.M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72, 248-254.
46. Ausubel,F.M. (1988) Current Protocols in Molecular Biology. Greene Pub. Associates and Wiley-Interscience, NY.
47. Yu,R., Mandlekar,S., Ruben,S., Ni,J. and Kong,A.N. (2000) Tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in androgen-independent prostate cancer cells. Cancer Res., 60, 2384-2389.
48. Cha-Molstad,H., Agrawal,A., Zhang,D., Samols,D. and Kushner,I. (2000) The Rel family member P50 mediates cytokine-induced C-reactive protein expression by a novel mechanism. J. Immunol., 165, 4592-4597.
49. Lin,Y.Z., Yao,S.Y., Veach,R.A., Torgerson,T.R. and Hawiger,J. (1995) Inhibition of nuclear translocation of transcription factor NF-kappa B by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence. J. Biol. Chem., 270, 14255-14258.
50. Huang,Z.-Q., Li,J., Sachs,L.M., Cole,P.A. and Wong,J. (2003) A role for cofactor-cofactor and cofactor-histone interactions in targeting p300, SWI/SNF and Mediator for transcription. EMBO J., 22, 2146-2155.
51. Kingston,R.E. and Narlikar,G.J. (1999) ATP-dependent remodeling and acetylation as regulators of chromatin fluidity. Genes Dev., 13, 2339-2352.
52. Cirillo,L.A., McPherson,C.E., Bossard,P., Stevens,K., Cherian,S., Shim,E.Y., Clark,K.L., Burley,S.K. and Zaret,K.S. (1998) Binding of the winged-helix transcription factor HNF3 to a linker histone site on the nucleosome. EMBO J., 17, 244-254.
53. McPherson,C.E., Shim,E.Y., Friedman,D.S. and Zaret,K.S. (1993) An active tissue-specific enhancer and bound transcription factors existing in a precisely positioned nucleosomal array. Cell, 75, 387-398.
54. Kaufmann,E. and Knochel,W. (1996) Five years on the wings of fork head. Mech. Dev., 57, 3-20.
55. Xuan,S., Baptista,C.A., Balas,G., Tao,W., Soares,V.C. and Lai,E. (1995) Winged helix transcription factor BF-1 is essential for the development of the cerebral hemispheres. Neuron, 14, 1141-1152.
56. Mendel,D.B. and Crabtree,G.R. (1991) HNF-1, a member of a novel class of dimerizing homeodomain proteins. J. Biol. Chem., 266, 677-680.
57. Janne,M. and Hammond,G.L. (1998) Hepatocyte nuclear factor-4 controls transcription from a TATA-less human sex hormone-binding globulin gene promoter. J. Biol. Chem., 273, 34105-34114.
58. Skala,H., Porteu,A., Thomas,M., Szajnert,M.F., Okazawa,H., Kahn,A. and Phan-Dinh-Tuy,F. (1998) Upstream elements involved in vivo in activation of the brain-specific rat aldolase C gene. Role of binding sites for POU and winged helix proteins. J. Biol. Chem., 273, 31806-31814.
59. Pfahl,M. (1993) Nuclear receptor/AP-1 interaction. Endocr. Rev., 14, 651-658.
60. Angel,P., Imagawa,M., Chiu,R., Stein,B., Imbra,R.J., Rahmsdorf,H.J., Jonat,C., Herrlich,P. and Karin,M. (1997) Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor. Cell, 49, 729-739.
61. Lee,W., Mitchell,P. and Tjian,R. (1987) Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements. Cell, 49, 741-752.
62. Lin,M.F., Lee,M.S., Garcia-Arenas,R. and Lin,F.F. (2000) Differential responsiveness of prostatic acid phosphatase and prostate-specific antigen mRNA to androgen in prostate cancer cells. Cell Biol. Int., 24, 681-689.
63. Sato,N., Sadar,M.D., Bruchovsky,N., Saatcioglu,F., Rennie,P.S., Sato,S., Lange,P.H. and Gleave,M.E. (1997) Androgenic induction of prostate-specific antigen gene is repressed by protein-protein interaction between the androgen receptor and AP-1/c- Jun in the human prostate cancer cell line LNCaP. J. Biol. Chem., 272, 17485-17494.
64. Sun,Z., Pan,J. and Balk,S.P. (1997) Androgen receptor-associated protein complex binds upstream of the androgen-responsive elements in the promoters of human prostate-specific antigen and kallikrein 2 genes. Nucleic Acids Res., 25, 3318-3325.
65. Edwards,D.R., Rocheleau,H., Sharma,R.R., Wills,A.J., Cowie,A., Hassell,J.A. and Heath,J.K. (1992) Involvement of AP1 and PEA3 binding sites in the regulation of murine tissue inhibitor of metalloproteinases-1 (TIMP-1) transcription. Biochim. Biophys. Acta, 1171, 41-55.
66. Kim,I.Y., Ahn,H.J., Zelner,D.J., Shaw,J.W., Sensibar,J.A., Kim,J.H., Kato,M. and Lee,C. (1996) Genetic change in transforming growth factor beta (TGF-beta) receptor type I gene correlates with insensitivity to TGF-beta 1 in human prostate cancer cells. Cancer Res., 56, 44-48.
67. Chen,C.D. and Sawyers,C.L. (2002 ) NF-[kappa]B activates prostate-specific antigen expression and is upregulated in androgen-independent prostate cancer. Mol. Cell. Biol., 22, 2862-2870.
68. McKay,L.I. and Cidlowski,J.A. (1999) Molecular control of immune/inflammatory responses: interactions between nuclear factor-[kappa]B and steroid receptor-signaling pathways. Endocr. Rev., 20, 435-459.
69. Baeuerle,P.A. and Henkel,T. (1994) Function and activation of NF-kappa B in the immune system. Annu. Rev. Immunol., 12, 141-179.
70. Saito,T., Takahashi,Y., Hashimoto,H. and Kamataki,T.(2001) Novel transcriptional regulation of the human CYP3A7 gene by Sp1 and Sp3 through nuclear factor kappa B-like element. J. Biol. Chem., 276, 38010-38022.
71. Chang,Y.H., Hsieh,S.L., Chen,M.C. and Lin,W.W. (2002) Lymphotoxin beta receptor induces interleukin 8 gene expression via NF-kappaB and AP-1 activation. Exp. Cell Res., 278, 166-174.
72. Espinosa,L., Santos,S., Ingles-Esteve,J., Munoz-Canoves,P. and Bigas,A. (2002) p65-NFkappaB synergizes with Notch to activate transcription by triggering cytoplasmic translocation of the nuclear receptor corepressor N-CoR. J. Cell Sci., 115, 1295-1303.
73. Kim,D.W., Gazourian,L., Quadri,S.A., Romieu-Mourez,R., Sherr,D.H. and Sonenshein,G.E. (2000) The RelA NF-kappaB subunit and the aryl hydrocarbon receptor (AhR) cooperate to transactivate the c-myc promoter in mammary cells. Oncogene, 19, 5498-5506.
74. Berkowitz,B., Huang,D.B., Chen-Park,F.E., Sigler,P.B. and Ghosh,G. (2002) The x-ray crystal structure of the NF-κB p50-p65 heterodimer bound to the interferon β-κB site. J. Biol. Chem., 277, 24694-24700.
75. Malek,S., Huang,D.B., Huxford,T., Ghosh, S., and Ghosh,G. (2003) X-ray crystal structure of an IκBβ.NF-κB p65 homodimer complex. J. Biol. Chem., 278, 23094-23100.
76. 2 complexed to a high-affinity RNA aptamer. Proc. Natl. Acad. Sci. USA, 100, 9268-9273.
77. Udalova,I.A., Richardson,A., Denys,A., Smith,C., Ackerman,H., Foxwell,B. and Kwiatkowski (2000) Functional consequences of a polymorphism affecting NF-kB p50-p50 binding to the TNF promoter region. Mol. Cell. Biol., 20, 9113-9119.